Leafix Medical Overview
LeaFix developed the only Transcatheter Functional Mitral valve Regurgitation repair solution, performed by an augmentation of the anterior leaflet. The system is composed of an implant and a delivery system, used for implantation of an implant into the anterior leaflet while expanding the implant within the leaflet, hence enlarging the leaflet area and creating coaptation of the leaflets.
Cumulative Funding Raised Over Time ($)
Latest News
שנה לאחר האקזיט הענק: מנתח הלב חושף סטארט-אפ חדש
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $6.5M |
| Last funding | $5M |
| Stage | Seed |
| Rounds | 2 |
| Investors | 1 |
Team Members
1
Employees: 1-10
Web & Social Links
| Website | www.leafix-medical.com |
Locations
Givat Brenner, Israel
Photos & Videos
No files yet
